Close
Close

Dana-Farber Cancer Institute - Multiple Myeloma in Relapse

Partner

Not provided

Rare Disease

Multiple Myeloma in Relapse

Sponsor

Dana-Farber Cancer Institute

Access Program Information

Participant that has been diagnosed with Relapsed/ Refractory Multiple Myeloma and are currently participating in a clinical trial which is closing. This research study is studying Ulocuplumab as a possible treatment. It's an expanded access from NCT01359657

Contact

Contact: Irene M Ghobrial, MD (617-632-4198)

Locations
  • United States
  • Boston, Massachusetts, United States

Free Newsletter